2021
Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes.
Pishesha, N. and Harmand, T. and Smeding, L.Y. and Ma, W. and Ludwig, L.S. and Janssen, R. and Islam, A. and Xie, Y.J. and Fang, T. and McCaul, N. and Pinney, W. and Sugito, H.R. and Rossotti, M.A. and Gonzalez-Sapienza, G. and Ploegh, H.L.
Nature Biomedical Engineering 5
(11): 1389-1401.
November 2021
CRISPR-based diagnostics.
Kaminski, M.M. and Abudayyeh, O.O. and Gootenberg, J.S. and Zhang, F. and Collins, J.J.
Nature Biomedical Engineering 5
(7): 643-656.
July 2021
2020
A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection.
Kaminski, M.M. and Alcantar, M.A. and Lape, I.T. and Greensmith, R. and Huske, A.C. and Valeri, J.A. and Marty, F.M. and Klämbt, V. and Azzi, J. and Akalin, E. and Riella, L.V. and Collins, J.J.
Nature Biomedical Engineering 4
(6): 601-609.
June 2020
2017
Enhanced precision and efficiency.
Bashir, S. and Kühn, R.
Nature Biomedical Engineering 1
(11): 856-857.
November 2017
Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods.
Churko, J.M. and Lee, J. and Ameen, M. and Gu, M. and Venkatasubramanian, M. and Diecke, S. and Sallam, K. and Im, H. and Wang, G. and Gold, J.D. and Salomonis, N. and Snyder, M.P. and Wu, J.C.
Nature Biomedical Engineering 1
(10): 826-837.
October 2017
This list was generated on Sat Apr 20 02:36:45 2024 CEST.